Table 2: Frequency distribution of factors that likely influence the progression of renal disease.
|
Treatment Group |
No |
Yes |
|
No |
Yes |
chi-square |
||
|
Variable present |
|
No |
No |
Total |
Yes |
Yes |
Total |
p-value |
|
Age ≥ 50 |
N |
1866 |
7337 |
9204 |
7889 |
31369 |
39258 |
0.6927 |
|
% group |
19.13 |
18.96 |
80.87 |
81.04 |
||||
|
BMI ≥ 30 |
N |
350 |
13487 |
16838 |
6405 |
25219 |
31624 |
0.3514 |
|
|
% group |
34.34 |
34.85 |
65.66 |
65.15 |
|||
|
Hypertension |
N |
8880 |
35261 |
44140 |
876 |
3446 |
4321 |
0.8199 |
|
% group |
91.02 |
91.1 |
8.98 |
8.9 |
||||
|
Diabetes Mellitus 2 |
N |
6687 |
26557 |
33244 |
3068 |
12150 |
15217 |
0.9119 |
|
% group |
68.55 |
68.61 |
31.45 |
31.39 |
||||
|
Uprot ≥ 30 mg |
N |
8200 |
32529 |
40730 |
1555 |
6177 |
7732 |
0.9617 |
|
% group |
84.06 |
84.04 |
15.94 |
15.96 |
||||
|
Self ID as Black |
N |
9385 |
37228 |
46613 |
370 |
1478 |
1848 |
0.8959 |
|
% group |
96.21 |
96.18 |
3.79 |
3.82 |
||||
|
ACE or ARB |
N |
5669.83 |
22481.2 |
28151.1 |
4085.27 |
16224.9 |
20310.1 |
0.9432 |
|
% group |
58.12 |
58.08 |
41.88 |
41.92 |
41.91 |
Note: These factors (left column) were used in the propensity analysis (inversed individual weight) matching. Results were grouped by the presence/absence of each factor and the treatment group.
Abbreviations: BMI: Body mass index; Uprot: Urinary protein; ID: Identification (race/ethnic); ACE: Angiotensin-converting-enzyme; ARB: Angiotensin-receptor blocker.